Directory

>

Anna Protopapas

avatar

Anna Protopapas

Chairperson of the Board | Mersana Therapeutics

Cambridge, Massachusetts, United States

View contact details (it's free)

Anna Protopapas

Summary

Anna Protopapas is a seasoned executive with over two decades of leadership experience in the biopharmaceutical and biotechnology sectors. She served as the President and CEO of Mersana Therapeutics from 2015 until her retirement in 2023, during which she significantly advanced the company's platform and pipeline in antibody-drug conjugates. Her prior roles include President of Millennium Pharmaceuticals and Executive Vice President at Takeda Pharmaceuticals, where she played a pivotal role in global business development and strategic acquisitions. Anna is currently the Chairperson of the Board at Nuvalent, Inc. and has held board positions at several other pharmaceutical companies. She holds degrees from prestigious institutions including Princeton, MIT, and Stanford, highlighting her strong educational background in engineering and business. Residing in Cambridge, Massachusetts, Anna is also known for her philanthropic efforts and commitment to mentoring the next generation of leaders in the life sciences industry.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Industry-specific interests

Leadership Development

Innovation

Organisational experience

Corporate Experience

Startup Experience

Anna Protopapas

Work Experience

company logo

Chairperson of the Board at

Nuvalent, Inc.

March 2022 - Present

company logo

Board Member at

Mersana Therapeutics

March 2015 - Present

company logo

President and CEO - Retired at

Mersana Therapeutics

March 2015 - September 2023

company logo

Board Member at

Novo Nordisk Inc.

January 2019 - June 2021

💼

Board Member at

Bioverativ

January 2017 - January 2018

company logo

Board Member at

Takeda Pharmaceuticals America, Inc.

May 2015 - January 2017

company logo

Executive Vice President and Corporate Officer, Global Licensing and Business Development at

TAKEDA PHARMACEUTICALS SRL

October 2010 - October 2014

company logo

President at

Takeda Pharmaceuticals America, Inc.

April 2013 - October 2014

company logo

Senior Vice President, Corporate and Business Development at

Takeda Oncology

October 2003 - October 2010

company logo

Vice President Of Business Development at

Millennium Pharmaceuticals

September 1997 - October 2003

Logos provided by Logo.dev

Anna Protopapas

Education

Massachusetts Institute of Technology, Master Of Science In Engineering

Princeton University, Bachelor Of Science In Engineering

The English School, Nicosia, Cyprus

Frequently Asked Questions about Anna Protopapas

What is Anna Protopapas email address?

Anna Protopapas's primary email address is ***********@mersana.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Anna Protopapas work for?

Anna Protopapas is a Chairperson of the Board at Mersana Therapeutics, a company specializing in Commercial physical research.

Where Anna Protopapas graduated from?

Anna Protopapas holds a degree in Chemical Engineering from Massachusetts Institute of Technology.

How can I directly contact Anna Protopapas?

To contact Anna Protopapas directly, you can use the email address ***********@mersana.com. Complete contact information is available upon registration with Muraena.

Is Anna Protopapas an immigrant?

Yes, Anna Protopapas is an immigrant and currently based in United States

Who is Anna Protopapas?

Anna Protopapas is a seasoned executive with over two decades of leadership experience in the biopharmaceutical and biotechnology sectors. She served as the President and CEO of Mersana Therapeutics from 2015 until her retirement in 2023, during which she significantly advanced the company's platform and pipeline in antibody-drug conjugates. Her prior roles include President of Millennium Pharmaceuticals and Executive Vice President at Takeda Pharmaceuticals, where she played a pivotal role in global business development and strategic acquisitions. Anna is currently the Chairperson of the Board at Nuvalent, Inc. and has held board positions at several other pharmaceutical companies. She holds degrees from prestigious institutions including Princeton, MIT, and Stanford, highlighting her strong educational background in engineering and business. Residing in Cambridge, Massachusetts, Anna is also known for her philanthropic efforts and commitment to mentoring the next generation of leaders in the life sciences industry.

Anna`s contact details

mail

***********@mersana.com

***************@mpi.com

Colleagues

avatar
Orhan Karsligil

VP, Information, Technology and Risk

avatar
Sam Kay Cfa

Executive Director - Business Development & Corporate Strategy

avatar
Alejandra Carvajal

SVP, Chief Legal Officer

Sue Monahan

Executive Director, Supplier Quality Drug Substance

avatar
Rishi Bhattacharjee

Vice President, Clinical Quality Assurance

avatar
Tarek Abdeljawad

Executive Director, Sterile Drug Products

avatar
Michael Kaufman

Chief Manufacturing Officer

Mohan Bala

Chief Development Officer

avatar
Sandra Mcmanus

Vice President of Quality, Manufacturing

avatar
June Buchanan

Executive Director Clinical Operations

View Contact details (it's free)
Request Profile Removal